BioSpace News Archive

Tumor Necrosis Factor is a crucial protein that plays crucial part in stimulating the human immunity system.

Vifor Pharma announced the appointment of Gregory Oakes as EVP, President North America and member of the Vifor Pharma Executive Committee as of September 1, 2020.

BerGenBio ASA, a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical need, is pleased to announce that a member of the senior management team will be presenting at the following virtual conferences:

Sparta Group has entered into an agreement with Encompass Power Solutions Corp to distribute the entire line of Encompass products and services, as well as develop correlative technology.

People with asthma encouraged to take new Reliever Reliance Test that assesses levels of reliance on their SABA ‘blue’ inhaler and supports relevant consultations with health professionals

Aptorum Group Limited, a biopharmaceutical company focused on the development of novel therapeutics including orphan diseases and oncology indications, announced further positive data from its latest in vivo studies showing significant activity against neuroblastoma tumor reduction when treated with its lead compound SACT-1 in combination with standard of care chemotherapy.

Aptorum Group Limited announced two sets of positive data showing both significant in vivo activities of its lead compound ALS-4 against Methicillin-Resistant Staphylococcus aureus in wound infected and bacteraemia mouse models, respectively when compared to prevailing antibiotics.

Envirotainer, the global market leader in secure cold chain solutions for air transport of pharmaceuticals, announced that they are expanding their network of stations by adding Beijing, China, to the growing list of e-technology network stations.

Isofol Medical AB, has announced that the company has further strengthened its position in the second largest market for treatment of mCRC by obtaining two new patent grants for arfolitixorin in Japan.

The global Healthcare Finance Solutions market is expected to achieve a stellar growth in the coming years of the forecast period.